MA S686

Bill

Promoting continuity of care for multiple sclerosis treatment

Introduced
03/29/2021

In Committee
02/17/2022

Crossed Over

Passed

Dead
12/31/2022

Introduced Session

192nd General Court

Bill Summary

For legislation to promote continuity of care for multiple sclerosis treatment. Financial Services.

AI Summary

This bill requires health insurance plans in Massachusetts, including the state's Group Insurance Commission, to provide coverage for multiple sclerosis (MS) drugs that an individual has already been prescribed and taking. Prior to receiving documentation of the individual's MS diagnosis and stabilization on the drug, the plan must provide a one-time 30-day transition fill or infusion of the drug. The bill also specifies that the coverage for these MS drugs cannot be subject to higher deductibles, coinsurance, or out-of-pocket limits than other MS drugs covered by the plan. The transition period does not apply to new MS drugs not yet reviewed by the plan's Pharmacy and Therapeutics committee, sample products, or drugs prescribed inconsistently with FDA indications.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (16)

John Keenan (D)*, John Barrett (D), Mike Barrett (D), Angelo D'Emilia (R), Diana Dizoglio (D), Mindy Domb (D), Jamie Eldridge (D), Paul Feeney (D), Sean Garballey (D), Hannah Kane (R), Patrick Kearney (D), Ed Kennedy (D), Mike Moore (D), James Murphy (D), Brian Murray (D), Patrick O'Connor (R),

Last Action

Accompanied H1089 (on 05/05/2022)

Official Document

https://malegislature.gov/Bills/192/S686

(8 Companion Bills)

Version:

Document Type	Source Location
State Bill Page	https://malegislature.gov/Bills/192/S686
Bill	https://malegislature.gov/Bills/192/S686.pdf

Bill	Bill Name	Last Action	Type
H1089	Promoting continuity of care for Multiple Sclerosis treatment	No further action taken	Similar To
H2098	Relative to creating intensive stabilization and treatment units within the Department of Mental Health	Accompanied a study order, see H5194	Similar To
H3637	Resolutions urging the Congress of the United States to update the Drug Addiction Treatment Act of 2000 and remove excessive training requirements mandated for obtaining a waiver to prescribe buprenorphine	No further action taken	Similar To
H4109	Relative to collaborative drug therapy management optimization	Accompanied S2492	Similar To
S1491	Relative to stroke protocols	Accompanied a study order, see S3173	Similar To
S2492	Relative to collaborative drug therapy management optimization	Accompanied a study order, see S2917	Similar To
S671	Relative to long-term care insurance consumer protections	Accompanied a study order, see S2693	Similar To
S795	Providing transparency for patients receiving care at hospital-based facilities	Accompanied a study order, see S2917	Similar To

Bill > S686

MA S686

summary

Introduced Session

Bill Summary

AI Summary

Committee Categories

Sponsors (16)

Last Action

Official Document

bill text

bill summary

bill summary

bill summary